Peptides.

Short chains of amino acids that copy a hormone. Insulin is one. Ozempic is one. Healing peptides like BPC-157, TB-500, ipamorelin and CJC-1295, the "Wolverine stack", are sold as the sequel: if a peptide can switch off hunger, another can heal your tendon, grow your muscle, slow your aging. Ozempic proved the needle. The craze sells the needle without the proof.

60% men and 40% women, aged 35 to 60: gym-goers, ex-athletes, biohackers, longevity-clinic clients, for weight (40%), injury recovery (25%), anti-aging (20%) and performance (15%). Because the doctor says rest and the influencer says inject. No government counts them: they buy by phone or online, mix Chinese powder with sterile water in the kitchen, and inject themselves.

Not yet. The entire published human record on BPC-157, the most injected healing peptide, is 1 small study of 12 patients, with no human safety data. Rodents heal. Humans have barely been tested. Non-approved peptides with a large human trial: 0. In July 2026 an FDA panel shaped by RFK Jr. recommended 6 of 7 peptides for prescription compounding anyway, 8 votes to 6, against the FDA's own scientists: a recommendation, not an approval. My call: BPC-157 gets its first 1,000-person trial by 2030, or the market learns nobody will fund one.

By 2030 healing peptides are legal by phone across the US, under tighter rules than the promoters expect, after the FDA's July 2026 panel recommended 6 of 7 for prescription compounding. Europe and the UK still ban them. BPC-157 gets its first 1,000-person trial or the market learns nobody will fund one, and the first peptide death lawsuit reaches a US court. The legal market outside GLP-1s and insulin is about $5 billion a year; the GLP-1 money, about $100 billion, is on my GLP-1 card.

Very. Of 469 BPC-157 samples tested in 2026, 68% failed on quality, doses off by up to 80%. Why: a peptide is cheap to copy and the FDA's 2023 crackdown pushed users to "research use only" vendors. Crypto-paid peptide sales pass $100 million a year. 2 women in Las Vegas ended in hospital after unknown peptides at an anti-aging clinic. If it did not come from a pharmacy with your name on it, do not inject it.

Ozempic, Wegovy, Mounjaro and Zepbound are peptides: short chains of amino acids that copy the gut hormone GLP-1, which tells your brain you are full and slows your stomach. Novo Nordisk and Eli Lilly built them for type 2 diabetes. Users lose 15 to 20% of body weight, which makes them the biggest weight-loss drugs in history.

Because a peptide is cheap to copy. Fake Ozempic pens filled with insulin sent buyers in Austria and the UK to hospital. Chinese labs ship raw semaglutide powder online as "research peptides", and wellness clinics stack it with unapproved healing peptides like BPC-157. If it did not come from a pharmacy with your name on the label, do not inject it.